Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volume Kinetics of 20% Albumin
NCT02556580Phase 4Unknown
- Sponsor
- Södertälje sjukhus
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of albumin (human) in hypovolemia (3 arms), sponsored by Södertälje sjukhus. Primary endpoint: Degree of plasma volume expansion at 5 hours. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT02556580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556580.